Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2026-01-02 @ 9:28 AM
Study NCT ID:
NCT01134250
Status:
COMPLETED
Last Update Posted:
2022-04-15
First Post:
2010-05-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients
Sponsor:
Philogen S.p.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PH-F16IL2TAXO-05/07
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None